478 related articles for article (PubMed ID: 33183965)
1. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel PR; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G; Elbert A; Faro A; Goss CH; Gulmans V; Gutierrez H; de Monestrol I; Jung A; Justus LN; Kashirskaya N; Marshall BC; McKone E; Middleton PG; Mondejar-Lopez P; Pastor-Vivero MD; Padoan R; Rizvi S; Ruseckaite R; Salvatore M; Stephenson AL; Filho LVRDS; Melo J; Zampoli M; Carr SB;
J Cyst Fibros; 2020 Nov; 19(6):868-871. PubMed ID: 33183965
[TBL] [Abstract][Full Text] [Related]
2. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tješić-Drinković D; Yiallouros P; Bilkova A; Olesen HV; Burgel PR; Parulava T; Diamantea F; Párniczky A; McKone EF; Mei-Zahav M; Salvatore M; Colombo C; Aleksejeva E; Malakauskas K; Schlesser M; Fustik S; Turcu O; Zomer-van Ommen D; Wathne AS; Woźniacki Ł; Pereira L; Pop L; Kashirskaya N; Rodić M; Kayserova H; Krivecs U; Mondejar-Lopez P; de Monestrol I; Dogru D; Makukh H; Cosgriff R; van Koningsbruggen-Rietschel S; Jung A;
J Cyst Fibros; 2021 Jul; 20(4):566-577. PubMed ID: 34016559
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
[TBL] [Abstract][Full Text] [Related]
4. Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis.
Radtke T; Haile SR; Dressel H; Benden C
J Cyst Fibros; 2020 Nov; 19(6):875-879. PubMed ID: 32878732
[TBL] [Abstract][Full Text] [Related]
5. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
Mondejar-Lopez P; Quintana-Gallego E; Giron-Moreno RM; Cortell-Aznar I; Ruiz de Valbuena-Maiz M; Diab-Caceres L; Prados-Sanchez C; Alvarez-Fernandez A; Garcia-Marcos PW; Peñalver-Mellado C; Pastor-Vivero MD; Olveira C; Lopez-Neyra A; Castillo-Corullon S; Palma-Milla S; Perez-Ruiz E; Sole-Jover A; Barrio MI; Sanchez-Solis M; Asensio de la Cruz Ó;
Respir Med; 2020; 170():106062. PubMed ID: 32843180
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
7. Sars-CoV-2 infection in patients with cystic fibrosis. An overview.
Fainardi V; Longo F; Chetta A; Esposito S; Pisi G
Acta Biomed; 2020 Sep; 91(3):e2020035. PubMed ID: 32921729
[TBL] [Abstract][Full Text] [Related]
8. The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients.
Havermans T; Houben J; Vermeulen F; Boon M; Proesmans M; Lorent N; de Soir E; Vos R; Dupont L
J Cyst Fibros; 2020 Nov; 19(6):880-887. PubMed ID: 32768311
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Carr SB; McClenaghan E; Elbert A; Faro A; Cosgriff R; Abdrakhmanov O; Brownlee K; Burgel PR; Byrnes CA; Cheng SY; Colombo C; Corvol H; Daneau G; Goss CH; Gulmans V; Gutierrez H; Harutyunyan S; Helmick M; Jung A; Kashirskaya N; McKone E; Melo J; Middleton PG; Mondejar-Lopez P; de Monestrol I; Nährlich L; Padoan R; Parker M; Pastor-Vivero MD; Rizvi S; Ruseckaite R; Salvatore M; da Silva-Filho LVRF; Versmessen N; Zampoli M; Marshall BC; Stephenson AL;
J Cyst Fibros; 2022 Jul; 21(4):e221-e231. PubMed ID: 35753987
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 outcomes in people with cystic fibrosis.
Burgel PR; Goss C
Curr Opin Pulm Med; 2021 Nov; 27(6):538-543. PubMed ID: 34620788
[TBL] [Abstract][Full Text] [Related]
11. An aging population of patients with cystic fibrosis undergoes lung transplantation: An analysis of the ISHLT Thoracic Transplant Registry.
Benden C; Goldfarb SB; Stehlik J
J Heart Lung Transplant; 2019 Nov; 38(11):1162-1169. PubMed ID: 31353276
[TBL] [Abstract][Full Text] [Related]
12. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.
Benden C; Haile S; Kruegel N; Beyeler F; Aubert JD; Binet I; Golshayan D; Hadaya K; Mueller T; Parvex P; Immer F
Swiss Med Wkly; 2020 Dec; 150():w20451. PubMed ID: 33382903
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.
Mathew HR; Choi MY; Parkins MD; Fritzler MJ
BMC Pulm Med; 2021 May; 21(1):173. PubMed ID: 34016096
[TBL] [Abstract][Full Text] [Related]
15. A 78-Year-Old Woman With Diarrhea and Respiratory Failure.
Mahieu R; Léger M; Dubillot M; Demiselle J
Chest; 2021 Mar; 159(3):e159-e162. PubMed ID: 33678285
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.
Colombo C; Alicandro G; Daccó V; Gagliano V; Morlacchi LC; Casciaro R; Pisi G; Francalanci M; Badolato R; Bignamini E; Messore B; Lucanto MC; Leonetti G; Maschio M; Cipolli M;
PLoS One; 2021; 16(5):e0251527. PubMed ID: 33984027
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.
Bain R; Cosgriff R; Zampoli M; Elbert A; Burgel PR; Carr SB; Castaños C; Colombo C; Corvol H; Faro A; Goss CH; Gutierrez H; Jung A; Kashirskaya N; Marshall BC; Melo J; Mondejar-Lopez P; de Monestrol I; Naehrlich L; Padoan R; Pastor-Vivero MD; Rizvi S; Salvatore M; Filho LVRFDS; Brownlee KG; Haq IJ; Brodlie M
J Cyst Fibros; 2021 Jan; 20(1):25-30. PubMed ID: 33309057
[TBL] [Abstract][Full Text] [Related]
18. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
[No Abstract] [Full Text] [Related]
19. Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.
Joy M; Hobbs FR; Bernal JL; Sherlock J; Amirthalingam G; McGagh D; Akinyemi O; Byford R; Dabrera G; Dorward J; Ellis J; Ferreira F; Jones N; Oke J; Okusi C; Nicholson BD; Ramsay M; Sheppard JP; Sinnathamby M; Zambon M; Howsam G; Williams J; de Lusignan S
Br J Gen Pract; 2020 Dec; 70(701):e890-e898. PubMed ID: 33077508
[TBL] [Abstract][Full Text] [Related]
20. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
